Cover Image
市場調查報告書

Daewoong Pharmaceutical Co., Ltd. - 產品平台分析

Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 224570
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
Daewoong Pharmaceutical Co., Ltd. - 產品平台分析 Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016
出版日期: 2016年08月17日 內容資訊: 英文 58 Pages
簡介

Daewoong Pharmaceutical Co., Ltd.是韓國數一數二的處方藥製造商之一。可將藥劑製成錠劑、膠囊、軟膏、注射、液體、噴劑等各種型式商品化,尤其從事於骨骼及關節相關疾病治療藥及心血管疾病治療藥、中樞神經治療藥、循環系統劑等各種領域的產品。

本報告提供Daewoong Pharmaceutical Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Daewoong Pharmaceutical Co., Ltd.的基本資料

Daewoong Pharmaceutical Co., Ltd.概要

  • 主要資訊
  • 企業資料

Daewoong Pharmaceutical Co., Ltd.:R&D概要

  • 主要的治療範圍

Daewoong Pharmaceutical Co., Ltd.:開發平台評估▼各開發階段的開發中產品

  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Daewoong Pharmaceutical Co., Ltd.:開發中產品概況▼最後階段的開發中產品

登記前的產品/聯合治療模式 第三階段的產品/聯合治療模式 ▼臨床實驗階段的開發中產品 第二階段的產品/聯合治療模式 第一階段的產品/聯合治療模式 ▼初期階段產品開發中產品 前臨床階段的產品/聯合治療模式 藥物研發中的產品/聯合治療模式

Daewoong Pharmaceutical Co., Ltd.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Daewoong Pharmaceutical Co., Ltd.:藥物簡介

  • aclidinium bromide
  • (rosuvastatin calcium + olmesartan medoxomil)
  • DWJ-1261
  • IMD-4
  • nepidermin
  • onabotulinumtoxinA biosimilar
  • DWP-05195
  • DWJ-204
  • DWP-09031
  • DWP-10292
  • DWP-418
  • etanercept biosimilar
  • DWJ-1308
  • DWJ-1325
  • DWJ-206
  • DWJ-208
  • DWJ-800
  • DWP-451
  • DWP-455
  • DWJ-1330
  • DWJ-1340
  • DWJ-1341
  • DWJ-205
  • DWJ-209
  • Undisclosed Program
  • (aclidinium bromide + formoterol fumarate)

Daewoong Pharmaceutical Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Daewoong Pharmaceutical Co., Ltd.:最近的開發平台趨勢

Daewoong Pharmaceutical Co., Ltd.:暫停中的計劃

Daewoong Pharmaceutical Co., Ltd.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • lagociclovir

Daewoong Pharmaceutical Co., Ltd.:企業發表

Daewoong Pharmaceutical Co., Ltd.:總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08117CDB

Summary

Global Markets Direct's, 'Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016', provides an overview of the Daewoong Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Daewoong Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Daewoong Pharmaceutical Co., Ltd.
  • The report provides overview of Daewoong Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Daewoong Pharmaceutical Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Daewoong Pharmaceutical Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Daewoong Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Daewoong Pharmaceutical Co., Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Daewoong Pharmaceutical Co., Ltd.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Daewoong Pharmaceutical Co., Ltd. Snapshot
    • Daewoong Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Daewoong Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Daewoong Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Daewoong Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Daewoong Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Daewoong Pharmaceutical Co., Ltd. - Drug Profiles
    • DWJ-1261
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • nepidermin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • onabotulinumtoxin A
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (olmesartan medoxomil + rosuvastatin calcium)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-05195
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWC-20151
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWC-20152
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-09031
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-10292
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-14012
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1303
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1308
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1325
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1340
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1351
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1355
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1365
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1366
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-206
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-208
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-209
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-06081
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Protein for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-1367
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-205
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWJ-210
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DWP-457
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline Analysis
    • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Target
    • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
    • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
    • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
  • Daewoong Pharmaceutical Co., Ltd. - Recent Pipeline Updates
  • Daewoong Pharmaceutical Co., Ltd. - Dormant Projects
  • Daewoong Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • lagociclovir
  • Daewoong Pharmaceutical Co., Ltd. - Company Statement
  • Daewoong Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Daewoong Pharmaceutical Co., Ltd., Key Information
  • Daewoong Pharmaceutical Co., Ltd., Key Facts
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Indication, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pre-Registration, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Phase III, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Phase II, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Phase I, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Preclinical, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Discovery, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Target, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2016
  • Daewoong Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2016
  • Daewoong Pharmaceutical Co., Ltd., Other Locations
  • Daewoong Pharmaceutical Co., Ltd., Subsidiaries

List of Figures

  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Target, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016
  • Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Back to Top